Global Pharmaceuticals & Biotech Best Growth Stocks

Axsome Therapeutics

Market Cap: US$5.9b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Zevra Therapeutics

Market Cap: US$535.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Camurus

Market Cap: SEK 40.6b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.

Caris Life Sciences

Market Cap: US$8.4b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

PharmaResearch

Market Cap: ₩6.2t

Operates as a biopharmaceutical company primarily in South Korea.

Oscotec

Market Cap: ₩1.8t

Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.

AprilBioLtd

Market Cap: ₩697.3b

AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.

Bonesupport Holding

Market Cap: SEK 19.2b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Xbrane Biopharma

Market Cap: SEK 671.2m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

PharmaEssentia

Market Cap: NT$190.5b

A biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥13.1b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

argenx

Market Cap: €37.8b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Botanix Pharmaceuticals

Market Cap: AU$313.8m

Operates as a commercial dermatology company in Australia and the United States.

Xiamen Amoytop Biotech

Market Cap: CN¥34.2b

Engages in research, development, production, and sale of recombinant protein drugs in China.

EZZ Life Science Holdings

Market Cap: AU$107.1m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia.

Cutia Therapeutics

Market Cap: HK$3.1b

An investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products, and skin care products in the People’s Republic of China and Hong Kong.

Newron Pharmaceuticals

Market Cap: CHF 216.0m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Legend Biotech

Market Cap: US$6.1b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Mesoblast

Market Cap: AU$3.0b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Lotus Pharmaceutical

Market Cap: NT$68.2b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Boji Medical TechnologyLtd

Market Cap: CN¥3.8b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.3b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Dizal (Jiangsu) Pharmaceutical

Market Cap: CN¥33.3b

Dizal (Jiangsu) Pharmaceutical Co., Ltd. discovers, develops, and commercializes medicines in the areas of cancer and immunological diseases.

ARS Pharmaceuticals

Market Cap: US$960.6m

A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.

Madrigal Pharmaceuticals

Market Cap: US$9.9b

A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

SKAN Group

Market Cap: CHF 1.2b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Soleno Therapeutics

Market Cap: US$3.6b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

Evoke Pharma

Market Cap: US$10.1m

Operates as a specialty pharmaceutical company that focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases.

ACADIA Pharmaceuticals

Market Cap: US$3.6b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

ADMA Biologics

Market Cap: US$3.5b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Alterity Therapeutics

Market Cap: AU$97.9m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

Clinuvel Pharmaceuticals

Market Cap: AU$591.5m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

Vanda Pharmaceuticals

Market Cap: US$290.1m

A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.

Achieve Life Sciences

Market Cap: US$161.0m

A late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom.

Orchid Pharma

Market Cap: ₹35.6b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.